// App-Quantinova.ai

207 : Novel Digital Technologies for the Assessment of Objective Measures and PROs in Patients with Rheumatoid Arthritis: A Pilot Study Using Smart Devices and a Bespoke Mobile App

Researchers

Presenter

  • Christopher Llop

Principal Investigators

  • Valentin Hamy

  • Christopher W Yee

  • Luis Garcia-Gancedo

  • Aoife Maxwell

  • Wen-Hung Chen

  • Ryan Tomlinson

  • Priyanka Bobbili

  • Julien Bendelac

  • Jessica Landry

  • Maral DerSarkissian

  • Mihran Yenikomshian

  • Elinor A Mody

  • Mei Sheng Duh

  • Rachel Williams

Medical Centers

  • GlaxoSmithKline, London, United Kingdom

  • Analysis Group, Inc., Boston, MA

  • GlaxoSmithKline, Philadelphia, PA.

  • GlaxoSmithKline, Stevenage, United Kingdom.

  • GlaxoSmithKline, Value Evidence and Outcomes, Philadephia

  • Analysis Group, Inc., Los Angeles, CA

  • Reliant Medical Group, Worcester, MA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved